These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18685502)

  • 1. Which role for prebiotics at weaning?
    Fanaro S; Vigi V
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S209-13. PubMed ID: 18685502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of prebiotics and food to intestinal microflora.
    Blaut M
    Eur J Nutr; 2002 Nov; 41 Suppl 1():I11-6. PubMed ID: 12420111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prebiotics on human health.
    Bruzzese E; Volpicelli M; Squaglia M; Tartaglione A; Guarino A
    Dig Liver Dis; 2006 Dec; 38 Suppl 2():S283-7. PubMed ID: 17259092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial-gut interactions in health and disease. Prebiotics.
    Manning TS; Gibson GR
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):287-98. PubMed ID: 15123070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics.
    Macfarlane GT; Steed H; Macfarlane S
    J Appl Microbiol; 2008 Feb; 104(2):305-44. PubMed ID: 18215222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prebiotics in human milk: a review.
    Coppa GV; Zampini L; Galeazzi T; Gabrielli O
    Dig Liver Dis; 2006 Dec; 38 Suppl 2():S291-4. PubMed ID: 17259094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The piglet as a model for studying dietary components in infant diets: effects of galacto-oligosaccharides on intestinal functions.
    Alizadeh A; Akbari P; Difilippo E; Schols HA; Ulfman LH; Schoterman MH; Garssen J; Fink-Gremmels J; Braber S
    Br J Nutr; 2016 Feb; 115(4):605-18. PubMed ID: 26653138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prebiotic effects of inulin and oligofructose.
    Kolida S; Tuohy K; Gibson GR
    Br J Nutr; 2002 May; 87 Suppl 2():S193-7. PubMed ID: 12088518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infant formulas supplemented with prebiotics: intestinal microbiota and immune responses].
    Fanaro S; Vigi V
    Minerva Pediatr; 2008 Jun; 60(3):327-35. PubMed ID: 18487978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary modulation of the human gut microflora using prebiotics.
    Gibson GR
    Br J Nutr; 1998 Oct; 80(4):S209-12. PubMed ID: 9924286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the intestinal microflora using probiotics and prebiotics.
    Fuller R; Gibson GR
    Scand J Gastroenterol Suppl; 1997; 222():28-31. PubMed ID: 9145443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a quantitative approach for determining the in vitro prebiotic potential of dietary oligosaccharides.
    Vulevic J; Rastall RA; Gibson GR
    FEMS Microbiol Lett; 2004 Jul; 236(1):153-9. PubMed ID: 15212805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prebiotics and their long-term influence on the microbial populations of the mouse bowel.
    Santos A; San Mauro M; Díaz DM
    Food Microbiol; 2006 Aug; 23(5):498-503. PubMed ID: 16943043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures.
    Mäkeläinen H; Saarinen M; Stowell J; Rautonen N; Ouwehand AC
    Benef Microbes; 2010 Jun; 1(2):139-48. PubMed ID: 21840802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study.
    Fanaro S; Marten B; Bagna R; Vigi V; Fabris C; Peña-Quintana L; Argüelles F; Scholz-Ahrens KE; Sawatzki G; Zelenka R; Schrezenmeir J; de Vrese M; Bertino E
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):82-8. PubMed ID: 19172129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligofructose and experimental model of neonatal necrotising enterocolitis.
    Butel MJ; Waligora-Dupriet AJ; Szylit O
    Br J Nutr; 2002 May; 87 Suppl 2():S213-9. PubMed ID: 12088521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intestinal bacterial colonisation in preterm infants: a review of the literature.
    Westerbeek EA; van den Berg A; Lafeber HN; Knol J; Fetter WP; van Elburg RM
    Clin Nutr; 2006 Jun; 25(3):361-8. PubMed ID: 16677741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal flora during the first months of life: new perspectives.
    Edwards CA; Parrett AM
    Br J Nutr; 2002 Sep; 88 Suppl 1():S11-8. PubMed ID: 12215177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary xylo-oligosaccharide stimulates intestinal bifidobacteria and lactobacilli but has limited effect on intestinal integrity in rats.
    Christensen EG; Licht TR; Leser TD; Bahl MI
    BMC Res Notes; 2014 Sep; 7():660. PubMed ID: 25238818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.